Figure 4. Kaplan-Meier analyses of six significant genes in patients with NFPA. Patients with upregulation of FAM90A1, ETS2 and STAT6 are less likely to have tumour regrowth (A–C). Patients with downregulation of MYT1L, ING2 and KCNK1 are less likely to have tumour regrowth (D–F).